138 related articles for article (PubMed ID: 22762724)
1. Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review.
Pulla VK; Battu MB; Alvala M; Sriram D; Yogeeswari P
Expert Opin Ther Targets; 2012 Aug; 16(8):819-32. PubMed ID: 22762724
[TBL] [Abstract][Full Text] [Related]
2. A Review on SIRtuins in Diabetes.
Aditya R; Kiran AR; Varma DS; Vemuri R; Gundamaraju R
Curr Pharm Des; 2017; 23(16):2299-2307. PubMed ID: 28128062
[TBL] [Abstract][Full Text] [Related]
3. The brain: a new organ for the metabolic actions of SIRT1.
Al Massadi O; Quiñones M; Lear P; Dieguez C; Nogueiras R
Horm Metab Res; 2013 Dec; 45(13):960-6. PubMed ID: 23950036
[TBL] [Abstract][Full Text] [Related]
4. A novel SIRT1 activator E6155 improves insulin sensitivity in type 2 diabetic KKA
Liu P; Feng T; Zuo X; Wang X; Luo J; Li N; Han X; Zhu N; Xu S; Xu Y; Jin ZG; Si S
Biochem Biophys Res Commun; 2018 Apr; 498(3):633-639. PubMed ID: 29524414
[TBL] [Abstract][Full Text] [Related]
5. Metabolic benefits from Sirt1 and Sirt1 activators.
Chaudhary N; Pfluger PT
Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):431-7. PubMed ID: 19474719
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 and insulin resistance.
Cao Y; Jiang X; Ma H; Wang Y; Xue P; Liu Y
J Diabetes Complications; 2016; 30(1):178-83. PubMed ID: 26422395
[TBL] [Abstract][Full Text] [Related]
7. Proposed Tandem Effect of Physical Activity and Sirtuin 1 and 3 Activation in Regulating Glucose Homeostasis.
Pacifici F; Di Cola D; Pastore D; Abete P; Guadagni F; Donadel G; Bellia A; Esposito E; Salimei C; Sinibaldi Salimei P; Ricordi C; Lauro D; Della-Morte D
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557786
[TBL] [Abstract][Full Text] [Related]
8. Sirtuins as possible drug targets in type 2 diabetes.
Kitada M; Kume S; Kanasaki K; Takeda-Watanabe A; Koya D
Curr Drug Targets; 2013 Jun; 14(6):622-36. PubMed ID: 23445543
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between SIRT1 and endocrine factors: effects on energy homeostasis.
Quiñones M; Al-Massadi O; Fernø J; Nogueiras R
Mol Cell Endocrinol; 2014 Nov; 397(1-2):42-50. PubMed ID: 25109279
[TBL] [Abstract][Full Text] [Related]
10. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1.
Fröjdö S; Durand C; Molin L; Carey AL; El-Osta A; Kingwell BA; Febbraio MA; Solari F; Vidal H; Pirola L
Mol Cell Endocrinol; 2011 Mar; 335(2):166-76. PubMed ID: 21241768
[TBL] [Abstract][Full Text] [Related]
11. The SIRT1 deacetylase protects mice against the symptoms of metabolic syndrome.
Caron AZ; He X; Mottawea W; Seifert EL; Jardine K; Dewar-Darch D; Cron GO; Harper ME; Stintzi A; McBurney MW
FASEB J; 2014 Mar; 28(3):1306-16. PubMed ID: 24297700
[TBL] [Abstract][Full Text] [Related]
12. SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications.
Kume S; Uzu T; Kashiwagi A; Koya D
Endocr Metab Immune Disord Drug Targets; 2010 Mar; 10(1):16-24. PubMed ID: 20044906
[TBL] [Abstract][Full Text] [Related]
13. Sirtuins: novel targets for metabolic disease.
Elliott PJ; Jirousek M
Curr Opin Investig Drugs; 2008 Apr; 9(4):371-8. PubMed ID: 18393104
[TBL] [Abstract][Full Text] [Related]
14. SIRT1: a promising therapeutic target in type 2 diabetes mellitus.
Mihanfar A; Akbarzadeh M; Ghazizadeh Darband S; Sadighparvar S; Majidinia M
Arch Physiol Biochem; 2024 Feb; 130(1):13-28. PubMed ID: 34379994
[TBL] [Abstract][Full Text] [Related]
15. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
16. [Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients].
Wawryka J; Barg E
Pediatr Endocrinol Diabetes Metab; 2016; 22(2):60-65. PubMed ID: 28329774
[TBL] [Abstract][Full Text] [Related]
17. Sirtuin 1 (SIRT1): the misunderstood HDAC.
Stünkel W; Campbell RM
J Biomol Screen; 2011 Dec; 16(10):1153-69. PubMed ID: 22086720
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B.
Sun C; Zhang F; Ge X; Yan T; Chen X; Shi X; Zhai Q
Cell Metab; 2007 Oct; 6(4):307-19. PubMed ID: 17908559
[TBL] [Abstract][Full Text] [Related]
19. Calorie restriction on insulin resistance and expression of SIRT1 and SIRT4 in rats.
Chen YR; Fang SR; Fu YC; Zhou XH; Xu MY; Xu WC
Biochem Cell Biol; 2010 Aug; 88(4):715-22. PubMed ID: 20651844
[TBL] [Abstract][Full Text] [Related]
20. Bovine sirtuins: initial characterization and expression of sirtuins 1 and 3 in liver, muscle, and adipose tissue.
Ghinis-Hozumi Y; González-Gallardo A; González-Dávalos L; Antaramian A; Villarroya F; Shimada A; Varela-Echavarría A; Mora O
J Anim Sci; 2011 Aug; 89(8):2529-36. PubMed ID: 21421831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
